Just a moment, the page is loading...

To initiate a Research Proposal or to Ask a Question about studies, please do the following:

  • Login and create an account.
  • Click on the Study ID to view Study Details.
  • If you cannot find the specific study you are looking for, click here to submit an Enquiry
×


5 Results:


Sponsor Studies ↑ Description Ready to Share Created
 
GSK GSK-102115 A dose-range study to assess the safety and immunogenicity of a novel HPV vaccine when administered intramuscularly according to a 3-dose schedule (0,1,6-month) in healthy adult females (18-25 years of age) No 3/31/2014
 
GSK GSK-108052 A long-term, follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ novel HPV vaccine in healthy female subjects vaccinated in the primary study No 3/31/2014
 
GSK GSK-107919 A dose-range study to assess the safety and immunogenicity of a novel HPV vaccine when administered intramuscularly according to a 3-dose schedule (0,1,6-month) in healthy adult females (18-25 years of age) No 3/31/2014
 
GSK GSK-107921 A double-blind, controlled, randomised, phase II study of the safety and immunogenicity of an HPV-VLP vaccine against Human Papillomavirus Types 16, 18, 31 and 45 evaluated in Healthy Adult Female Volunteers in a 0, 1, 6 months schedule No 4/1/2019
 
GSK GSK-107918 A double-blind, controlled, randomised, phase II study of the safety and immunogenicity of an HPV-VLP vaccine against Human Papillomavirus Types 16, 18, 31 and 45 evaluated in Healthy Adult Female Volunteers in a 0, 1, 6 months schedule No 4/1/2019